<DOC>
	<DOCNO>NCT01048242</DOCNO>
	<brief_summary>The objective study determine treatment Ramelteon help improve insomnia old adult co-existent insomnia sleep apnea . The primary study objective sleep latency ( measure insomnia ) . The hypothesis sleep latency reduce subject take Ramelteon relative placebo arm . The secondary study objective determine subject compliance CPAP treatment sleep apnea improved subject take Ramelteon ( compliance may improve would less insomnia due Ramelteon treatment use CPAP ) . The hypothesis compliance CPAP improve subject take Ramelteon relative placebo arm .</brief_summary>
	<brief_title>Treatment Insomnia Elderly Sleep Apnea Patients With Ramelteon ( TAK 375 )</brief_title>
	<detailed_description>Randomized , double-blind , placebo-controlled , parallel arm clinical trial two study arm .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Obstructive sleep apnea Insomnia Age &gt; 60 Cognitive impairment Active alcohol substance abuse Active use sedativehypnotic agent Active use fluvoxamine ( drug interaction Ramelteon Evidence hepatic dysfunction ( Ramelteon contraindicate ) liver function panel Presence Periodic Limb Movement Disorder Restless Legs Syndrome Severe COPD</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>